Trial Profile
Solifenacin Succinate versus Percutaneous Tibial Nerve Stimulation in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Crossover Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2014
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 02 Apr 2014 New trial record